Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

33.18p
   
  • Change Today:
    -0.100p
  • 52 Week High: 45.55p
  • 52 Week Low: 25.50p
  • Currency: UK Pounds
  • Shares Issued: 303.70m
  • Volume: 197,710
  • Market Cap: £100.75m
  • RiskGrade: 479
  • Beta: 0.87

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
66.50% above the market average66.50% above the market average66.50% above the market average66.50% above the market average66.50% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Price Book Ratio
96.05% below the market average96.05% below the market average96.05% below the market average96.05% below the market average96.05% below the market average
90.7% below the sector average90.7% below the sector average90.7% below the sector average90.7% below the sector average90.7% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
3.62% above the market average3.62% above the market average3.62% above the market average3.62% above the market average3.62% above the market average
12.00% above the sector average12.00% above the sector average12.00% above the sector average12.00% above the sector average12.00% above the sector average
Price Chg 3m
1.75% below the market average1.75% below the market average1.75% below the market average1.75% below the market average1.75% below the market average
12.00% above the sector average12.00% above the sector average12.00% above the sector average12.00% above the sector average12.00% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
31.71% above the market average31.71% above the market average31.71% above the market average31.71% above the market average31.71% above the market average
21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average
Momentum 20
14.74% below the market average14.74% below the market average14.74% below the market average14.74% below the market average14.74% below the market average
43.48% below the sector average43.48% below the sector average43.48% below the sector average43.48% below the sector average43.48% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
80.36% below the market average80.36% below the market average80.36% below the market average80.36% below the market average80.36% below the market average
16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
64.77% below the market average64.77% below the market average64.77% below the market average64.77% below the market average64.77% below the market average
22.45% below the sector average22.45% below the sector average22.45% below the sector average22.45% below the sector average22.45% below the sector average
Forecast EPS
96.14% below the market average96.14% below the market average96.14% below the market average96.14% below the market average96.14% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
61.39% below the market average61.39% below the market average61.39% below the market average61.39% below the market average61.39% below the market average
16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average
Operating Profit Loss
77.89% below the market average77.89% below the market average77.89% below the market average77.89% below the market average77.89% below the market average
38.78% below the sector average38.78% below the sector average38.78% below the sector average38.78% below the sector average38.78% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
33.93% below the market average33.93% below the market average33.93% below the market average33.93% below the market average33.93% below the market average
2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average
Cash
1.84% below the market average1.84% below the market average1.84% below the market average1.84% below the market average1.84% below the market average
18.37% above the sector average18.37% above the sector average18.37% above the sector average18.37% above the sector average18.37% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
18.22% below the market average18.22% below the market average18.22% below the market average18.22% below the market average18.22% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average
Buys 1y
28.73% above the market average28.73% above the market average28.73% above the market average28.73% above the market average28.73% above the market average
7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
65.01% above the market average65.01% above the market average65.01% above the market average65.01% above the market average65.01% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 33.18p
Change Today -0.100p
% Change -0.30 %
52 Week High 45.55p
52 Week Low 25.50p
Volume 197,710
Shares Issued 303.70m
Market Cap £100.75m
Beta 0.87
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
82.27% below the market average82.27% below the market average82.27% below the market average82.27% below the market average82.27% below the market average
88% below the sector average88% below the sector average88% below the sector average88% below the sector average88% below the sector average
Price Trend
10% below the market average10% below the market average10% below the market average10% below the market average10% below the market average
46.94% above the sector average46.94% above the sector average46.94% above the sector average46.94% above the sector average46.94% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:23 5 @ 33.65p
16:03 8,390 @ 32.83p
15:48 5,500 @ 32.83p
15:31 3,266 @ 32.65p
15:22 802 @ 32.67p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page